:: News p1
     News Archive
:: Conferences p2
:: Jobs p2
:: Grants & Awards p2
:: Business News p3
:: Books & Journals p4
:: Establishments p5

adaptiveoptics.org provides news and information for the world-wide adaptive optics community.
Contact: webmaster@adaptiveoptics.org.

Advanced Medical Optics Acquires WaveFront Sciences

Santa Ana, California – January 16, 2007:   Advanced Medical Optics, Inc. (AMO), a global ophthalmic surgical and eye care products company, today announced the acquisition of WaveFront Sciences, Inc., a leading provider of proprietary wavefront diagnostic systems for refractive surgery and medical research.
  WaveFront Sciences, Inc. designs and manufactures the industry's highest resolution Shack-Hartmann-based aberrometer, which precisely measures the total refractive error and wavefront aberrations of the human eye as part of the wavefront-guided custom laser vision correction procedure. The acquisition expands AMO's portfolio of industry-leading laser technologies and strengthens its pipeline of new wavefront-guided diagnostic innovations.

"WaveFront Sciences has earned an excellent reputation in the ophthalmic industry for its cutting-edge diagnostics," said AMO Chairman, President and CEO Jim Mazzo. "This acquisition represents another step forward in AMO's strategy to provide a full range of products and services that meets the needs of comprehensive refractive practices. With this transaction, we secure proprietary technologies and R&D expertise in wavefront sensing and laser optics, which we expect will allow us to further strengthen
Atlas of Laser Scanning Ophthalmoscopy, Scheuerle
our Advanced CustomVue™ laser vision correction technology and accelerate the introduction of next-generation diagnostics that build on our WaveScan Wavefront® systems."

AMO acquired WaveFront Sciences for approximately $20 million, including a $14 million cash payment at closing and an agreement to make a total of $6 million in future cash payments contingent on achievement of certain milestones over the next three years. Based in Albuquerque, New Mexico, WaveFront Sciences is a privately held company.

"WaveFront Sciences looks forward to supporting and contributing to AMO's growth and business objectives while enabling practitioners to provide state-of-the-art surgical planning and diagnostics for their patients," said WaveFront Sciences CEO Tim Turner.
AMO is the global laser vision correction leader. Its Advanced CustomVue™ procedure provides practitioners the widest FDA-approved custom LASIK treatment range on the market today. The WaveFront Sciences acquisition follows AMO's January 8 announcement of its intent to acquire IntraLase Corp., the leading provider of femtosecond laser technology, and define a new standard of laser vision correction care. AMO expects to complete the Intralase transaction in the second quarter of 2007.

About Advanced Medical Optics (AMO): 
AMO is a global medical device leader focused on the discovery and delivery of innovative vision technologies. Products in the ophthalmic surgical line include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery.

About WaveFront Sciences: 
WaveFront Sciences is the world's leading manufacturer of Shack-Hartmann based optical metrology with products for customized LASIK surgery, intraocular and contact lenses as well as conventional optical metrology. The company employs approximately 50 people.
Full Press Release

© 2007
              ^ [TOP]
<<   [1]  [2]  [3]  [4]  [5]  >>
'Surely You're Joking, Mr. Feynman!', Feynman